Mesenchymal Cell Therapy for Dilated Cardiomyopathy: Time to Test the Water

Affiliations

Free article

Editorial

Stefan P Janssens. J Am Coll Cardiol. 2017.

Free article

. 2017 Feb 7;69(5):538-540.

doi: 10.1016/j.jacc.2016.11.044.

¹ Department of Cardiovascular Diseases, University Hospital Leuven, Leuven, Belgium. Electronic address: stefan.janssens@med.kuleuven.be.

No abstract available

Keywords: allogeneic; apoptosis; heart failure; inflammation.

Comment on

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
Hare JM, DiFede DL, Rieger AC, Florea V, Landin AM, El-Khorazaty J, Khan A, Mushtaq M, Lowery MH, Byrnes JJ, Hendel RC, Cohen MG, Alfonso CE, Valasaki K, Pujol MV, Golpanian S, Ghersin E, Fishman JE, Pattany P, Gomes SA, Delgado C, Miki R, Abuzeid F, Vidro-Casiano M, Premer C, Medina A, Porras V, Hatzistergos KE, Anderson E, Mendizabal A, Mitrani R, Heldman AW. Hare JM, et al. J Am Coll Cardiol. 2017 Feb 7;69(5):526-537. doi: 10.1016/j.jacc.2016.11.009. Epub 2016 Nov 14. J Am Coll Cardiol. 2017. PMID: 27856208 Free PMC article. Clinical Trial.